Back to search

Sweden· SE-20061130000029

Ranexa 375 mg Depottablett

A medicinal product containing ranolazine, registered in Sweden by Menarini International Operations Luxembourg SA.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedRanexa 375 mg DepottablettATC—REGISTER NO.SE-20061130000029PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Ranolazine
Manufacturer
Menarini International Operations Luxembourg SA
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20061130000029

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ranolazine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ranolazine products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Rande, Ranogelan
  • Bulgaria · Равена
  • Cyprus · Ranolazine Accord, Ranolazine Remedica
  • Czechia · Ranolazine Umedica
  • Germany · Halibrell, Labigat
  • Denmark · Labigat
  • Estonia · Halibrell, Ralik
  • Spain · Labigat, Ranolazina Alter
  • France · Ranolazine Micro Labs
  • United Kingdom (Northern Ireland) · Ranolazine, Ranolazine Accord
  • Greece · Labigat, Lakosun
  • Croatia · Halibrell, Lasokun
  • Ireland · Ranolazine Accord, Ranolazine Clonmel
  • Iceland · Ranexa
  • Italy · Labigat, Ranolazina Accord
  • Liechtenstein · Ranexa
  • Lithuania · Halibrell, Lasokun
  • Latvia · Halibrell, Lasokun
  • Netherlands · Lazela, Ranogelan
  • Norway · Ranexa
  • Poland · Ralik, Ranolazine Aurovitas
  • Portugal · Ranolazina Adamed, Ranolazina Bluepharma
  • Romania · Ranolazina Atb
  • Slovenia · Halibrell, Ranolazin Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2761ecb8-50d3-4844-9e85-120d767242be
GET /v1/drugs/2761ecb8-50d3-4844-9e85-120d767242be?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EPAR",
    "EMA"
  ],
  "se_npl_id": "20061130000029",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20061130000029",
  "product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/ranexa-epar-product-information_sv.pdf"
}

See everything about ranolazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.